Get the Stockscreener App
10.52
1.35%
0.16
Immatics N V stock is traded at $10.52, with a volume of 99,670.
It is up +1.35% in the last 24 hours and up +80.41% over the past month.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
See More
Previous Close:
$10.36
Open:
$10.5
24h Volume:
99,670
Relative Volume:
0.13
Market Cap:
$1.28B
Revenue:
$58.49M
Net Income/Loss:
$-105.04M
P/E Ratio:
-8.0942
EPS:
-1.2997
Net Cash Flow:
$-13.78M
1W Performance:
+11.82%
1M Performance:
+80.41%
6M Performance:
+153.62%
1Y Performance:
+12.42%
1-Day Range:
$10.42
$10.74
1-Week Range:
$9.0975
$10.95
52-Week Range:
$3.30
$10.95
Immatics N V Stock (IMTX) Company Profile
Compare IMTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IMTX
Immatics N V
|
10.52 | 1.26B | 58.49M | -105.04M | -13.78M | -1.2997 |
|
VRTX
Vertex Pharmaceuticals Inc
|
406.42 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.57 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
549.52 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
800.57 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
328.93 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Immatics N V Stock (IMTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Initiated | Guggenheim | Buy |
| May-28-25 | Initiated | Deutsche Bank | Buy |
| Oct-07-24 | Initiated | Piper Sandler | Overweight |
| Nov-02-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-31-23 | Initiated | Mizuho | Buy |
| Mar-24-23 | Initiated | Bryan Garnier | Buy |
| Nov-20-20 | Initiated | BofA Securities | Buy |
| Sep-22-20 | Initiated | Goldman | Buy |
| Jul-27-20 | Initiated | SVB Leerink | Outperform |
| Jul-24-20 | Initiated | Jefferies | Buy |
View All
Immatics N V Stock (IMTX) Latest News
How Immatics N.V. stock responds to policy changesMarket Trend Summary & Community Verified Trade Signals - newser.com
Published on: 2025-10-12 23:02:40 - newser.com
Is now a turning point for Immatics N.V.Market Trend Summary & Consistent Profit Trade Alerts - newser.com
Can Immatics N.V. stock rebound after recent weaknessBond Market & Safe Capital Investment Plans - newser.com
Will Immatics N.V. rebound enough to break even2025 Short Interest & Accurate Buy Signal Notifications - newser.com
Will Immatics' (IMTX) New CFO Appointment Reshape Its Long-Term Growth and Transformation Strategy? - simplywall.st
Is Immatics N.V. (4A3) stock vulnerable to rate hikesWeekly Stock Recap & Real-Time Volume Analysis - newser.com
What institutional flow reveals about Immatics N.V.Portfolio Value Summary & Short-Term Swing Trade Alerts - newser.com
Immatics (NASDAQ:IMTX) Reaches New 1-Year HighHere's What Happened - MarketBeat
Immatics: Multiple Clinical Catalysts In Q4'25 And 2026 (NASDAQ:IMTX) - Seeking Alpha
Why Immatics N.V. (4A3) stock is a must watch tickerEarnings Recap Report & Advanced Swing Trade Entry Alerts - newser.com
How sentiment analysis helps forecast Immatics N.V. Equity WarrantEarnings Trend Report & Daily Market Momentum Tracking - newser.com
Immatics NV Hits Day High with 10.2% Surge Amid Strong Intraday Performance - Markets Mojo
Immatics NV Experiences Revision in Stock Evaluation Amid Mixed Market Indicators - Markets Mojo
Immatics NV Stock Analysis and ForecastMarket Volatility Update & You’ll Thank Yourself in 6 Months - earlytimes.in
Immatics N.V. stock trend forecast2025 Geopolitical Influence & Consistent Profit Trading Strategies - newser.com
Analyzing Immatics N.V. with risk reward ratio charts2025 Risk Factors & Trade Opportunity Analysis Reports - newser.com
Can technical indicators confirm Immatics N.V.’s reversalMarket Volume Report & Stock Timing and Entry Methods - newser.com
Immatics' (IMTX) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Reversal indicators forming on Immatics N.V. Equity Warrant stockDollar Strength & Real-Time Volume Surge Alerts - newser.com
How supply shortages influence Immatics N.V. (4A3) stock2025 Market WrapUp & Verified Momentum Stock Watchlist - newser.com
Using Bollinger Bands to evaluate Immatics N.V. Equity WarrantOptions Play & Step-by-Step Trade Execution Guides - newser.com
Is Immatics N.V. stock a dividend growth opportunityLong Setup & Reliable Breakout Stock Forecasts - newser.com
Using R and stats models for Immatics N.V. forecastingOil Prices & Free Technical Pattern Based Buy Signals - newser.com
Is Immatics N.V. stock ready for a breakoutBuy Signal & Technical Pattern Based Signals - newser.com
Will Immatics N.V. Equity Warrant rebound enough to break evenTrend Reversal & Consistent Growth Stock Picks - newser.com
Custom watchlist performance reports with Immatics N.V.July 2025 Action & Risk Controlled Stock Alerts - newser.com
Published on: 2025-10-05 03:07:55 - newser.com
Will Immatics (IMTX) Gain Momentum as New CFO Brings Biopharma Commercialization Expertise? - simplywall.st
Earnings visualization tools for Immatics N.V.Weekly Trade Analysis & Daily Oversold Stock Bounce Ideas - newser.com
Historical volatility pattern of Immatics N.V. visualizedMarket Performance Recap & Low Drawdown Investment Ideas - newser.com
Published on: 2025-10-03 05:43:05 - newser.com
Candlestick signals on Immatics N.V. Equity Warrant stock todayJuly 2025 Drop Watch & High Return Trade Opportunity Guides - newser.com
Published on: 2025-10-03 03:04:39 - newser.com
What analyst consensus says on Immatics N.V. Equity Warrant stockStop Loss & High Accuracy Swing Entry Alerts - newser.com
Reversal indicators forming on Immatics N.V. stockIPO Watch & Short-Term Swing Trade Alerts - newser.com
Published on: 2025-10-02 21:13:24 - newser.com
Immatics N V Stock (IMTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
2.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):